Harvard Wyss Institute’s eRapid multiplexed biosensor technology licensed to StataDX to enable new diagnostics for neurological, cardiovascular, and renal diseases

Technology Transfer News

Harvard Wyss Institute's eRapid multiplexed biosensor technology ... by so many promising diagnostic technologies – the successful transfer to ...

Related articles